
0:00
11:59
This episode: A probiotic strain of E. coli can target and destroy pathogens that survive a treatment of antibiotics!
Download Episode (8.2 MB, 12 minutes)
Show notes:
Microbe of the episode: Streptomyces griseoruber
In this study, a probiotic strain of Escherichia coli was used to target potentially pathogenic E. coli bacteria that can survive treatment with a particularly effective type of antibiotic, fluoroquinolones. This probiotic strain, called Nissle, delivers toxins directly to the survivors, preventing resistant pathogens from proliferating.
Journal Paper:
Hare PJ, Englander HE, Mok WWK. 2022. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment. J Appl Microbiol 132:4020–4032.
Email questions or comments to bacteriofiles at gmail dot com. Thanks for listening!
Subscribe: Apple Podcasts, Google Podcasts, Android, or RSS. Support the show at Patreon, or check out the show at Twitter or Facebook.
Flere episoder fra "BacterioFiles"



Gå ikke glip af nogen episoder af “BacterioFiles” - abonnér på podcasten med gratisapp GetPodcast.








